- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Care models come together
Two leading industry groups put their heads together for seemless care
LITTLE ROCK, ARK., AND WASHINGTON-When it comes to cost control, integrated care and improved communication among caregivers are among the most frequently cited needs.
Those needs are at the heart of a collaborative effort between the Little Rock, Ark.-based Case Management Society of America (CMSA) and the Washington, D.C.-based DMAA: The Care Continuum Alliance (DMAA). In October, the two industry groups announced the creation of a taskforce that will define the relationship between case management and population health management.
Working together, the organizations plan to develop a consensus statement detailing the interactions between case and population health management strategies and devise a roadmap for quality-based programs for the chronically ill.
Despite the overlap, the two fields have historically acted independently, leading to duplication of services, unnecessary expenses and less than optimal care.
Case management focuses on meeting an individual's comprehensive health needs through assessment, planning, facilitation and coordination of care, according to CMSA. DMAA's definition of population health management emphasizes a central care delivery model led by the primary care physician, patient engagement and personal responsibility and the expansion of care through coordinated programs. While the interventions vary, the groups acknowledge there's a lot of overlap between their functions.
"The two fields are so integrated," says Lattimer. "If you continue to keep them siloed you continue to have a communication breakdown."
By working together, the two organizations will be able to devise more collaborative, coordinated models that translate to better patient care and reduce duplication of services. Until the silos come down, legislation will have little impact, she says.
"Communication isn't all about EMRs," she says. "It's about our processes, our basic communication strategy."
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
